Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Stagezero Life Sciences Ltd (SZLS.TO)

Stagezero Life Sciences Ltd (SZLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,909
  • Shares Outstanding, K 105,465
  • Annual Sales, $ 3,795 K
  • Annual Income, $ -11,415 K
  • 60-Month Beta -0.05
  • Price/Sales 1.12
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SZLS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.12
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 unch
on 04/08/24
0.0550 -27.27%
on 03/28/24
-0.0050 (-11.11%)
since 03/08/24
3-Month
0.0400 unch
on 04/08/24
0.0550 -27.27%
on 03/28/24
-0.0050 (-11.11%)
since 01/08/24
52-Week
0.0350 +14.29%
on 10/20/23
0.0950 -57.89%
on 04/12/23
-0.0500 (-55.56%)
since 04/06/23

Most Recent Stories

More News
GeneNews: Q3 Earnings Snapshot

GeneNews: Q3 Earnings Snapshot

SZLS.TO : 0.0400 (unch)
GeneNews: Q2 Earnings Snapshot

GeneNews: Q2 Earnings Snapshot

SZLS.TO : 0.0400 (unch)
StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting

Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special and...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
Stocks in play: StageZero Life Sciences

Today announced its first quarter financial results for the three months ended March 31, 2023. For the ...

SZLS.TO : 0.0400 (unch)
StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update

Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
GeneNews: Q1 Earnings Snapshot

GeneNews: Q1 Earnings Snapshot

SZLS.TO : 0.0400 (unch)
StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023

Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results after...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)
StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0400 (+48.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues...

See More

Key Turning Points

3rd Resistance Point 0.0400
2nd Resistance Point 0.0400
1st Resistance Point 0.0400
Last Price 0.0400
1st Support Level 0.0400
2nd Support Level 0.0400
3rd Support Level 0.0400

See More

52-Week High 0.0950
Fibonacci 61.8% 0.0721
Fibonacci 50% 0.0650
Fibonacci 38.2% 0.0579
Last Price 0.0400
52-Week Low 0.0350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar